Ladenburg Thalmann Financial Services’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-250	Closed	-$6K	–	5334
2017 Q4	$6K	Buy	250 +20	+9%	+$384	﹤0.01%	4487
2017 Q3	$4K	Hold	230	–	–	﹤0.01%	4528
2017 Q2	$4K	Hold	230	–	–	﹤0.01%	4442
2017 Q1	$3K	Hold	230	–	–	﹤0.01%	4517
2016 Q4	$4K	Hold	230	–	–	﹤0.01%	4371
2016 Q3	$5K	Hold	230	–	–	﹤0.01%	4215
2016 Q2	$4K	Hold	230	–	–	﹤0.01%	4248
2016 Q1	$4K	Hold	230	–	–	﹤0.01%	4214
2015 Q4	$4K	Hold	230	–	–	﹤0.01%	4189
2015 Q3	$4K	Hold	230	–	–	﹤0.01%	4083
2015 Q2	$6K	Hold	230	–	–	﹤0.01%	4008
2015 Q1	$5K	Buy	+230	New	+$4.96K	﹤0.01%	4019

Ladenburg Thalmann Financial Services's ENTL Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 250 shares — an estimated $6K sold.

Ladenburg Thalmann Financial Services first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $6K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Ladenburg Thalmann Financial Services reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 250 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $6K.
Ladenburg Thalmann Financial Services first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
Ladenburg Thalmann Financial Services's Entellus Medical, Inc. Common Stock position peaked at $6K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.